The Synuclein-One Study: An NIH-Sponsored Research Project
CND is seeking healthy volunteers who would like to participate in this important study which uses simple skin biopsies as part of the protocol. To learn more, click here and we will contact you soon.

Senior woman header
Senior woman header
Photo header of senior man
Photo header of senior man

DIAGNOSTIC INSIGHTS FOR LIFE

CND has launched the Syn-One Test™ to offer physicians and patients an accurate, evidence-based tool to help confirm a diagnosis of a synucleinopathy. And our mission has just begun.

Learn More
Senior woman header
Senior woman header
Senior man header
Photo header of senior man

DIAGNOSTIC INSIGHTS FOR LIFE

CND has launched the Syn-One Test™ to offer physicians and patients an accurate, evidence-based tool to help confirm a diagnosis of a synucleinopathy. And our mission has just begun.
Learn More

Introducing the Syn-One Test™ from CND Life Sciences

Offering physicians and patients an accurate, evidence-based tool to help confirm a diagnosis of a synucleinopathy.

seal icon

CLIA-Certified Pathology Lab

test tube icon

Dedication to Science & Research

DNA icon

Patient-Focused Mission

microscope icon

Quality & Reliability at Our Core

Clarity and Confidence of Syn-One

Having objective, visual proof of a disease process can be invaluable for physicians and patients. That’s why CND Life Sciences developed the Syn-One Test as a way to actually see the presence of abnormal alpha-synuclein in the skin–an important marker for Parkinson’s disease and other disorders known as synucleinopathies.  

Learn More

Our Commitment to Patients

We did not invent the saying “knowledge is power,” but we subscribe to this philosophy as part of our mission. Patients and caregivers rely on physicians to make vital clinical judgments every day, and we are committed to providing reliable diagnostic technologies and useful insights that help optimize care.

Learn more about what drives us.

Learn More

Read our perspectives on the industry, the field of neurodiagnostics, patient care, and other topics.

Insights
April 14, 2021

CND Life Sciences Launches New Awareness Campaign in Top Neurology Journals

In a new effort to increase awareness and adoption of the skin-based Syn-One Test™ for…
Insights
April 8, 2021

Raising Awareness on World Parkinson’s Day

Do you know how many people in the US are diagnosed with Parkinson’s disease each…
Insights
March 8, 2021

International Women’s Day 2021

Karina Solis always wanted to be a teacher. Her love for education took her from…
VIEW ALL INSIGHTS

Check out press releases, news alerts and coverage of CND happenings.

In the News
March 31, 2021

Phoenix Business Journal Covers $2.4 Million Seed Funding, Profiles CND

CND Life Sciences continues to build its presence as an exciting medical technology start-up. Phoenix…
News Release
March 23, 2021

CND Life Sciences Closes Series Seed Funding Round

Innovators of the Syn-One Test™ Building Market Presence and Infrastructure
In the News
March 4, 2021

Researchers Identify Five Genes Linked to Lewy Body Dementia

By identifying potential genetic causes of Lewy body dementia (LBD), researchers hope to gain a…
VIEW ALL NEWS
CND CASE STUDIES

For Clinicians: Request a Syn-One Test™ Kit

The Syn-One Test provides objective pathological evidence to aid in the diagnosis of a synucleinopathy. Simply collect three small punch skin biopsies from your patient, send them to our CLIA-certified lab, and CND Life Sciences will provide important visual insights to support a diagnosis. If you are a clinician, click below to order a Syn-One Test Biopsy Kit.

Order a Kit